Karthik Sekar

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Clonal diversity underpins distinct modes of recurrence in hepatocellular carcinoma: the PLANet cohort study.

Clonal diversity underpins distinct modes of recurrence in hepatocellular carcinoma: the PLANet cohort study.

Journal: Gut

Published: January 23, 2026

Multiomics and multi-region spatial transcriptome analysis reveal cellular networks and pathways associated with HCC recurrence.

Multiomics and multi-region spatial transcriptome analysis reveal cellular networks and pathways associated with HCC recurrence.

Journal: JHEP reports : innovation in hepatology

Published: July 09, 2025

Re-programming by a six-factor-secretome in the patient tumor ecosystem during nutrient stress and drug response.

Re-programming by a six-factor-secretome in the patient tumor ecosystem during nutrient stress and drug response.

Journal: iScience

Published: May 05, 2023

A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory.

A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory.

Journal: Journal of hepatology

Published: April 23, 2023

A genomic enhancer signature associates with hepatocellular carcinoma prognosis.

A genomic enhancer signature associates with hepatocellular carcinoma prognosis.

Journal: JHEP reports : innovation in hepatology

Published: September 06, 2022

Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.

Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.

Journal: BMC cancer

Published: June 10, 2022

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Journal: Nature communications

Published: February 22, 2021

Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.

Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.

Journal: Cancer research and treatment

Published: May 17, 2020

Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.

Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: July 24, 2019

NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.

NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.

Journal: International journal of cancer

Published: October 02, 2018

Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations.

Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations.

Journal: Scientific reports

Published: August 07, 2018

CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling.

CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling.

Journal: The EMBO journal

Published: March 07, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026